3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Hepatocellular
131
Liver Neoplasms
42
Carcinoma, Renal Cell
36
Leukemia, Myeloid, Acute
32
Neoplasm Metastasis
26
Breast Neoplasms
24
Carcinoma, Non-Small-Cell Lung
22
Kidney Neoplasms
16
Neoplasms
14
Prostatic Neoplasms
12
Pancreatic Neoplasms
12
Recurrence
11
Lung Neoplasms
11
Colorectal Neoplasms
10
Sarcoma
9
Melanoma
9
Brain Neoplasms
9
Myelodysplastic Syndromes
8
Glioblastoma
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Leukemia
6
Urinary Bladder Neoplasms
5
Thyroid Neoplasms
5
Rectal Neoplasms
5
Multiple Myeloma
5
Leukemia, Myelomonocytic, Chronic
5
Stomach Neoplasms
4
Ovarian Neoplasms
4
Liver Diseases
4
Gliosarcoma
4
Interventions
Gemcitabine
8
pembrolizumab
5
Cisplatin
5
enfortumab vedotin
3
avelumab
3
Specimen Handling
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Carboplatin
3
vinflunine
2
Radiotherapy
2
Nephroureterectomy
2
Immunoglobulin G
2
Doxorubicin
2
Disulfides
2
vandetanib
1
tremelimumab
1
tocilizumab
1
tamibarotene
1
relatlimab
1
pegfilgrastim
1
merphos
1
guadecitabine
1
genexol-PM
1
enzalutamide
1
durvalumab
1
dehydroftorafur
1
atezolizumab
1
abexinostat
1
Vitamin D
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Ureteral Neoplasms
×
Sorafenib
×
Clear all
NCT01844947
2019-04-26
VINSOR
Karolinska University Hospital
Phase 1
Completed
22 enrolled